Insights The High Cost of Standing Still: What Sponsors Risk by Ignoring ICH E6(R3) LinkedIn The Future Is Now: How Clinical Trial Sites Can Lead in the Era of ICH E6 (R3) LinkedIn Leading the Charge: Service Providers as Catalysts for the ICH E6(R3) Era LinkedIn Sign up to receive news and updates. Email Address Sign Up Thank you!